Division of Endocrinology, Department of Medicine, Columbia University, 180 Fort Washington Avenue, New York, NY, 10032, USA.
Department of Surgery, Columbia University, 180 Fort Washington Avenue, New York, NY, 10032, USA.
Endocrine. 2019 Dec;66(3):682-690. doi: 10.1007/s12020-019-02099-1. Epub 2019 Oct 3.
Screening for vertebral fractures (VF) in primary hyperparathyroidism (PHPT) is recommended, but there are limited data regarding which patients are at greatest risk for VF. We evaluated risk factors for VF in PHPT.
This is a retrospective cross-sectional analysis of 117 participants with PHPT. We assessed Grades 2 and 3 VF by vertebral fracture assessment (VFA) and the association of VF with the trabecular bone score (TBS), other skeletal parameters and clinical risk factors. VFA was performed only in those who met National Osteoporosis Foundation criteria for VFA screening.
T-scores were in the osteopenic range and TBS was degraded. Overall VF rate based on VFA or other imaging was 12.8%. Serum PTH, calcium and TBS were not associated with VF. Those with VF were older (p = 0.04), had worse renal function (p = 0.04), were more likely to have received osteoporosis treatment (p = 0.03), and tended to have had a prior fracture (p = 0.06). T-scores did not differ by fracture status at any skeletal site. Those with VF had nine times the odds of osteoporosis at the hip (95% CI 2.4-34.5), but this risk factor had low sensitivity (46.7%) for VF. Hip T-score < -2.6, Age > 78.6 years, and GFR < 58.8 ml/min/1.73 m (thresholds maximizing sensitivity and specificity) had areas under the curve of 0.60-0.67 for VF (all p < 0.05) and low sensitivity. Findings were similar when analyses were limited to women.
In PHPT, VF risk factors included older age, prior fracture, worse renal function and osteoporosis at the hip, but not osteoporosis at other sites, TBS or biochemical indices of PHPT. Since identified risk factors had low sensitivity and were generally inaccurate for categorizing those with VF, the data do not support limiting screening to PHPT patients with these specific VF risk factors.
原发性甲状旁腺功能亢进症(PHPT)患者建议进行椎体骨折(VF)筛查,但关于哪些患者存在最大的 VF 风险的相关数据有限。本研究旨在评估 PHPT 患者发生 VF 的相关风险因素。
这是一项针对 117 例 PHPT 患者的回顾性横断面分析。我们通过椎体骨折评估(VFA)评估了 2 级和 3 级 VF,并评估了 VF 与骨小梁评分(TBS)、其他骨骼参数和临床风险因素的相关性。仅对符合国家骨质疏松基金会 VFA 筛查标准的患者进行 VFA 检查。
骨密度 T 评分处于骨质疏松范围,TBS 降低。基于 VFA 或其他影像学检查,总体 VF 发生率为 12.8%。血清甲状旁腺激素(PTH)、钙和 TBS 与 VF 无关。患有 VF 的患者年龄较大(p=0.04),肾功能更差(p=0.04),更有可能接受骨质疏松治疗(p=0.03),且更倾向于发生过骨折(p=0.06)。在任何骨骼部位,骨折患者的 T 评分均无差异。患有 VF 的患者发生髋部骨质疏松的风险增加了 9 倍(95%CI 2.4-34.5),但该风险因素对 VF 的敏感性较低(46.7%)。髋部 T 评分<-2.6、年龄>78.6 岁和肾小球滤过率(GFR)<58.8ml/min/1.73m(最大限度提高敏感性和特异性的阈值)的患者 VF 的曲线下面积为 0.60-0.67(均 p<0.05),且敏感性较低。当分析仅限于女性时,结果相似。
在 PHPT 中,VF 的危险因素包括年龄较大、既往骨折、肾功能更差和髋部骨质疏松,但其他部位、TBS 或 PHPT 的生化指标与 VF 无关。由于确定的风险因素敏感性较低,并且通常无法准确分类 VF 患者,因此这些数据不支持将筛查仅限于具有特定 VF 风险因素的 PHPT 患者。